Not known Factual Statements About Block Pain Receptors with Proleviate
Having discovered the palmitoylation motif of APLNR, we developed a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web page in combination with morphine, can inhibit the event of NCP, including pain incidence, microglial activation, and inflam